Skip to content
Rameda Pharma
Rameda Pharma
  • IR Library
    • Results Center
    • Presentations and Publications
    • Board and Shareholders Actions
    • Our People
  • Share & Corporate Information
    • Key Information
    • Listing Information
    • Analyst Coverage
  • News and Disclosures
    • Corporate News
    • Regulatory Disclosures
  • IR Calendar
  • Corporate Governance
    • BOD Reports
    • Corporate Governance Reports
  • IR Contact
Corporate Website
  • ع
  • IR Library
    • Results Center
    • Presentations and Publications
    • Board and Shareholders Actions
    • Our People
  • Share & Corporate Information
    • Key Information
    • Listing Information
    • Analyst Coverage
  • News and Disclosures
    • Corporate News
    • Regulatory Disclosures
  • IR Calendar
  • Corporate Governance
    • BOD Reports
    • Corporate Governance Reports
  • IR Contact

Author Archives: admin

You are here:
  1. Home
  2. Article author admin

Annual ESG Disclosure Report

Regulatory DisclosuresBy adminMarch 7, 2023

Disclosure to EGX on BOD minutes

Regulatory DisclosuresBy adminMarch 7, 2023
Details

Board of Directors Report – FY22

Board and Shareholders ActionsBy adminMarch 7, 2023
Details

BOD Meeting Minutes on 6 March 2023

Board and Shareholders ActionsBy adminMarch 7, 2023

Rameda Reports its FY22 Results

Corporate NewsBy adminMarch 7, 2023

Disclosure to the EGX on the Organizational Structure

Regulatory DisclosuresBy adminJanuary 9, 2023

Disclosure to EGX on BOD minutes

Regulatory DisclosuresBy adminJanuary 5, 2023
ZoomDetails

2022 Annual Report

Annual ReportsBy adminDecember 30, 2022
Details

BOD Report FY2022

BOD ReportsBy adminDecember 30, 2022

Rameda acquires exclusive rights for the distribution and marketing of “Physiomer” in Egypt

Corporate NewsBy adminDecember 20, 2022
←1
23456
…7891011…
12131415161718192021222324252627282930313233343536
37→

All Rights Reserved © 2024

Go to Top